Which Cancers Can Be Targeted by DNA-PK Inhibitors?
DNA-PK inhibitors have shown promise in treating a variety of cancers, particularly those that are highly reliant on DNA repair mechanisms. These include breast cancer, prostate cancer, lung cancer, and certain types of leukemia. Research is ongoing to determine the full spectrum of cancers that may benefit from DNA-PK inhibition.
